Immediately after U.S. health officials linked Tylenol to autism, the drug's use in pregnant women visiting ERs dropped, new ...

Virtual chronic care company Omada, which went public less than a year ago, reported a quarterly profit for the first time.

Trump wants to focus on his efforts to lower drug prices, but the TrumpRx website is falling short of his promises.

Science Corp. raised $230 million as it awaits a decision from the FDA on PRIMA, their wireless retinal implant.

At a time when his vaccine policies are causing pushback from doctors, Kennedy's allies push nutrition education as an area ...

Mary Talley Bowden, who spent years in an expensive court battle with the Texas Medical Board over her license for ...

Spyre Therapeutics CEO Cameron Turtle talks about the search for an IBD treatment on this week's "The Readout LOUD." ...

South Africa has the world’s highest HIV burden, with about 8 million HIV-positive people, or 1 in 5 adults, as of last year.

A month after its launch, few drugs are available on TrumpRx and data about how much the site is being used remain unknown ...

Patients generate vast health data, but private companies monetize it. A policy group proposes treating the data like a regulated utility.

Cognito raised $105 million as it awaits trial data that it hopes will convince the FDA to authorize its Alzheimer’s treatment device.

Drug-pricing promises are colliding with reality: A month in, the TrumpRx platform still includes only a limited number of drugs and it’s unclear if the site is being widely used, STAT’s Daniel Payne ...